Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy

This study has been terminated.
(Lack of participations (8 of 25))
Sponsor:
Information provided by (Responsible Party):
Technische Universität München
ClinicalTrials.gov Identifier:
NCT00727207
First received: July 31, 2008
Last updated: December 13, 2012
Last verified: December 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: September 2014
  Primary Completion Date: May 2011 (Final data collection date for primary outcome measure)